GlaxoSmithKline reported GBP19.32B in Loan Capital for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Loan Capital Change
Alcon AG ALC:SW USD 4.19B 37M
Amgen AMGN:US USD 37.16B 1.46B
AstraZeneca AZN:LN USD 23.68B 3.47B
Bayer BAYN:GR EUR 39.46B 1.4B
Biogen BIIB:US USD 6.28B 1.8M
Bristol Myers Squibb BMY:US USD 36.97B 141M
Eli Lilly And LLY:US USD 14.14B 548.2M
Fresenius FRE:GR EUR 25.24B 607M
Fresenius Medical Care FME:GR EUR 12.41B 930M
Galapagos GLPG:NA EUR 15.76M 1.12M
Genmab GEN:DC DKK 550M 4M
GlaxoSmithKline GSK:LN GBP 19.32B 538M
Glaxosmithkline GSK:US GBP 21.56B 1.31B
Hikma Pharmaceutical HIK:LN USD 1.41B 689M
Lonza Group LONN:SW CHF 1.55B 393M
Merck MRK:GR EUR 9.27B 119M
Novartis NOVN:VX USD 21.24B 2.55B
Orion ORNBV:FH EUR 197.9M 5.4M
Philips PHIA:NA EUR 6.91B 122M
Recordati REC:IM EUR 1.4B 46.04M
Regeneron Pharmaceuticals REGN:US USD 2.7B 400K
Roche Holding ROG:VX 22.37B 6.29B
Smith & Nephew PLC SN/:LN 2.28B 567M